Sionna Therapeutics Inc.

NASDAQ: SION · Real-Time Price · USD
20.88
-0.03 (-0.14%)
At close: Aug 15, 2025, 3:06 PM

Sionna Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-70.56M -50.33M -41.37M
Interest Income
8.17M 2.77M 1.13M
Pretax Income
-61.69M -47.26M -40.24M
Net Income
-61.69M -47.26M -40.24M
Selling & General & Admin
12.6M 9.71M 6.77M
Research & Development
57.29M 40.63M 34.6M
Other Expenses
n/a n/a n/a
Operating Expenses
70.56M 50.33M 41.37M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
70.56M 50.33M 41.37M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
42.44M 27.8M 17.33M
Shares Outstanding (Diluted)
42.44M 27.8M 17.33M
EPS (Basic)
-1.45 -1.7 -2.32
EPS (Diluted)
-15.99 -1.7 -2.32
EBITDA
-69.89M -49.75M -41.25M
EBIT
-70.56M -50.33M -41.37M
Depreciation & Amortization
668K 583K 122K